<?xml version="1.0" encoding="UTF-8"?>
<p id="p0315">The global spending on cancer therapies, cholesterol-lowering drugs, malaria, spina bifida and anencephaly, osteoporosis, vaccine market and diabetes nowadays exceeds $ 5 trillion USD and, according to 
 <xref rid="bib180" ref-type="bibr">WHO</xref> is expected to grow at a compound annual growth rate of 5% in the next ten years period (
 <xref rid="bib181" ref-type="bibr">WHO, 2019a</xref>). According to 
 <xref rid="bib180" ref-type="bibr">WHO</xref>, the global total 2019 health cost is about 10 trillion USD, 10% of Gross National Product (GDP) and 1080 USD per capita (
 <xref rid="bib182" ref-type="bibr">WHO, 2019b</xref>). The total global cost for COVID-19 will be unknown for months, and it will likely have a substantial secondary cost burden for decades.
</p>
